Is HRT Effective in Menopausal Weight Gain?

Many women enter midlife doing everything “right.” Yet weight gain still creeps in. This frustrating shift is not a failure of willpower. It’s biology.

Menopause represents far more than the end of reproductive years; it marks an overall metabolic turning point. As hormone levels change, particularly estrogen, the body’s relationship with fat, muscle, and energy regulation changes with it. When estrogen levels decline, the body becomes more prone to storing fat in the abdominal region, losing lean muscle, and developing insulin resistance. That makes weight management more challenging, with or without changes in diet or activity.

With recently updated safety data released by the FDA this fall, hormone replacement therapy (HRT) deserves a re-examination as part of a comprehensive weight-support strategy during menopause. This long-overdue shift to remove the black box warnings opens the door to more accurate, individualized conversations about hormone therapy and the role it plays in supporting changing health parameters during menopause.

Menopause and Weight Gain

Hot flashes. Mood changes. Libido disruption. Weight gain. At the center of this shift is estrogen.

Before menopause, estrogen levels are cardio-protective and support metabolic health. As estrogen levels decline during the menopausal transition, fat storage can begin to shift away from the hips and thighs and toward the abdomen, increasing both subcutaneous and visceral fat. Subcutaneous fat is the layer of adipose tissue directly beneath your skin that provides insulation, energy, and cushioning – but excess amounts are linked to health issues like heart disease, diabetes, and certain cancers. Visceral fat is the deep abdominal adipose tissue surrounding internal organs, and has an even bigger impact on insulin resistance, inflammation, cardiovascular disease, and type 2 diabetes.

To complicate matters, as the weight distribution shifts, muscle mass naturally decreases with age. Because muscle tissue burns more calories at rest than fat, the loss of lean mass lowers resting metabolic rate; even though your eating habits or activity level haven’t changed, the weight seems to pile on because the body requires fewer calories to maintain its weight.

Several hormonal changes contribute to a perfect weight-gain storm:

• Declining estradiol (E2) Estradiol is the most active form of estrogen during reproductive years. As levels fall, cells become less sensitive to insulin, making it easier for glucose to be stored as fat.
• Lower sex hormone-binding globulin (SHBG) SHBG is a protein “buffer” that regulates how much testosterone and estrogen are biologically active in the body. When levels decline during menopause, a higher proportion of testosterone remains unbound and active, while overall estrogen levels are already falling. The imbalance favors fat storage in the abdominal region and is associated with insulin resistance and increased cardiometabolic risk.
• Rising follicle-stimulating hormone (FSH) FSH increases as the ovaries reduce estrogen production, and it is believed that elevated FSH may directly influence fat accumulation and energy regulation, contributing to increases in total fat mass independent of lifestyle changes.

To boot, menopause is also commonly accompanied by sleep disturbances, fatigue, joint pain, mood changes, and brain fog. That indirectly affects weight by reducing energy for movement, impairing recovery, and increasing stress-related eating. Due to these overlapping factors, researchers suggest that overall weight gain during menopause averages about one pound per year through a woman’s 50s.¹

Being a biologically predictable process, there are strategies we can employ, recognizing that the body’s internal signaling environment has changed. And with the recent changes in HRT warning labels, we can approach the conversation about weight loss more broadly and openly with patients.

Wait, What are the Black Box Warnings?

The original black box warnings date back to large studies in the early 2000s, known as the WHI trials. These studies were halted prematurely when researchers observed higher incidences of breast cancer, heart attacks, and strokes in participants using certain forms of systemic hormone therapy. The findings were dramatic, received widespread attention, and ultimately propelled the FDA to issue broad warnings for many hormone products, including local vaginal estrogen.

In November 2025, the FDA revisited these warnings following a scientific review, concluding that the warnings and potential dangers were overstated. After evaluating decades of follow-up research, updated scientific literature, and public input, including guidance from an Expert Panel convened in July 2025, the FDA determined that the risks highlighted in the original WHI studies do not accurately reflect the safety profile of modern systemic therapies or low-dose vaginal estrogen products.²

The Question at Hand…

… and the answer: hormone replacement therapy (HRT) is not a weight loss medication, at least not in the traditional sense – it doesn’t directly burn fat or suppress calories. What it does do is address the hormonal imbalances that undermine weight regulation during menopause.

By restoring estrogen levels closer to premenopausal ranges, HRT helps counter several of the metabolic shifts that make midlife weight gain so stubborn. When estrogen is reintroduced appropriately, it can blunt the postmenopausal shift toward belly fat accumulation and help preserve lean muscle mass. In practical terms, that means fewer calories are diverted to visceral fat storage and the body remains metabolically more efficient.

HRT is primarily useful in addressing weight gain indirectly by improving the symptoms that interfere with healthy habits in the first place – better sleep quality, reduced hot flashes, improved mood stability, and less joint pain. When patients feel better, adherence to nutrition and activity plans becomes more realistic and sustainable.

The scale may not drop dramatically with HRT alone, but body composition can stabilize or improve by removing many of the biological barriers that make weight loss during menopause feel like an uphill battle.

Holistic Weight Loss

With the FDA’s removal of outdated and unsupported black box warnings, HRT is now positioned as a safer, more accessible option for women navigating the metabolic challenges of menopause. At MIIS Wellness Institute, we’re excited to soon offer medically guided hormone therapy as part of a comprehensive approach to midlife health and weight loss.

Our goal is to support sustainable weight management, improve energy and overall wellbeing, and help patients feel at home in their changing bodies. By combining HRT with personalized nutrition guidance, IV and medical weight loss therapies, and surface-level body-shaping techniques like Botox and body contouring, we can address both the hormonal and lifestyle factors that influence weight, fat distribution, and metabolism.

Menopause is a natural transition, but with the right tools and support, you’re not “stuck dealing with it.” The team at MIIS Wellness is ready to guide you safely and confidently.

1. Knight, M. G., Anekwe, C., Washington, K., Akam, E. Y., Wang, E., & Stanford, F. C. (2021). Weight regulation in menopause. Menopause (New York, N.Y.), 28(8), 960–965. https://doi.org/10.1097/GME.0000000000001792.
2. U.S. Food and Drug Administration. (2025, November 10). FDA Requests Labeling Changes Related to HRT. FDA. https://www.fda.gov/drugs/drug-safety-and-availability/fda-requests-labeling-changes-related-safety-information-clarify-benefitrisk-considerations.